<DOC>
	<DOCNO>NCT02805218</DOCNO>
	<brief_summary>The purpose study estimate safety efficacy PEG-rhG-CSF patient lymphoma receive chemotherapy .</brief_summary>
	<brief_title>PEG-rhG-CSF Patients With Lymphoma Receiving Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Patients age â‰¥ 18 year diagnosis lymphoma ( Hodgkin 's lymphoma nonHodgkin 's lymphoma ) patient Karnofsky Performance Status Z70 life expectancy least 8 month normal white blood cell count platelet count Written inform consent acquire uncontrolled infection pregnancy Have accept antitumor drug within 4 week anticipate study Other situation investigator consider contraindication study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>